Related Experiment Video
Updated: May 12, 2026

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
SARS-CoV-2 in Infants: Clinical Patterns, Laboratory Findings, and Implications for Pediatric Care in Viral Outbreaks
Marwh G Aldriwesh1,2,3, Norah F Abukhalid1,2,3, Sarah M Alotaibi1,2,3
1Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Insights
COVID-19 in infants is generally mild, but younger infants (under 6 months) show increased vulnerability. This study highlights age-specific differences in symptoms and lab findings, emphasizing tailored care for pediatric COVID-19 patients.
Area of Science:
- Pediatric infectious diseases
- Viral pathogenesis in infants
- Public health and epidemiology
Background:
- COVID-19 (Coronavirus disease 2019) has significantly impacted global healthcare systems.
- While adult COVID-19 presentations are documented, data on infant infections, especially by age group, remain limited.
Purpose of the Study:
- To compare the clinical presentation, laboratory findings, and outcomes of infants diagnosed with COVID-19.
- To differentiate between infants aged 6 months or younger and those older than 6 months.
Main Methods:
- A retrospective cross-sectional study was conducted at a tertiary pediatric hospital in Saudi Arabia.
- Electronic medical records of 388 infants with confirmed COVID-19 (March 2020-December 2022) were analyzed.
- Demographic, clinical, laboratory, and outcome data were compared between infants aged ⩽6 months and >6 months.
Main Results:
- Infants aged ⩽6 months constituted 54.6% of the cohort. Fever, cough, and rhinorrhea were common symptoms.
- Diarrhea was more frequent in infants >6 months (58.6% vs. 41.4%).
- White blood cell abnormalities varied by age, with leukopenia in younger infants and leukocytosis in older infants. Mortality was low (1.03%), affecting primarily infants ⩽3 months with comorbidities.
Conclusions:
- SARS-CoV-2 infection in infants is typically mild with low mortality.
- Infants aged ⩽6 months exhibited greater clinical vulnerability compared to older infants.
- Findings support age-specific risk assessment and management strategies for pediatric COVID-19 cases.
Background:
The emergence of COVID-19 has placed unprecedented pressure on healthcare systems worldwide. Although the clinical features of COVID-19 are well-documented in adults, limited data are available regarding its impact on infants, particularly across different age groups.
Objectives:
To compare the clinical presentation, laboratory findings, and outcomes of infants aged ⩽6 months with those aged >6 months diagnosed with COVID-19.
Design:
Retrospective cross-sectional study.
Methods:
This study was conducted at a tertiary pediatric hospital in Saudi Arabia. Data were extracted from electronic medical records of 388 infants with confirmed COVID-19 between March 2020 and December 2022. Demographic information, clinical signs and symptoms, laboratory parameters, and clinical outcomes were analyzed and compared between the two age groups using appropriate statistical methods.
Results:
Among 388 infants diagnosed with COVID-19, 54.6% were aged ⩽6 months. Less than half of the cohort was symptomatic, with fever (41.0%), cough (37.1%), and rhinorrhea (20.1%) being the most common symptoms. Gastrointestinal symptoms differed significantly by age: infants >6 months had higher rates of diarrhea than those ⩽6 months (58.6% vs 41.4%, P = .028). Most infants had normal white blood cell (WBC) counts (76.5%), though WBC abnormalities varied by age group: leukopenia was more frequent in infants ⩽6 months, while leukocytosis was more common in older infants (P = .009). Elevated C-reactive protein was observed in 63.0% of tested infants, and hyperglycemia was detected in 83.6%. COVID-19-related mortality was low (1.03%), primarily affecting infants ⩽3 months with pre-existing comorbidities.
Conclusion:
SARS-CoV-2 infection in infants was generally mild, with low rates of complications and mortality. However, infants aged ⩽6 months demonstrated greater clinical vulnerability compared to older infants. These findings underscore age-specific differences in clinical presentation and support the need for tailored risk assessment and management approaches in pediatric care.
More Related Videos
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Infectious Diseases and Their Occurrence
Viral Meningitis
Cytomegalovirus Disease

